BioRestorative Therapies Inc
BRTX
$1.59-9.14%
End of day · as of Oct 14, 2026, 8:00 AM ET
Mkt cap
$10.18M
EV/Sales
24.1
P/E ratio
N/A
FY2025 Revenue
$359,700
EPS (9mo ended 2025-09-30)
$-1.26
Gross Margin (FY2025)
93.37%
Profit Margin (FY2025)
-3959.40%
Beta
N/A
Div yield
N/A
Sector
Healthcare
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
Use this BRTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BRTX income, balance, and cash tables.
BioRestorative Therapies Inc (BRTX) is a biotechnology company in the Healthcare sector.
Latest cached BioRestorative Therapies Inc (BRTX) revenue for Dec 31, 2025 was $359.7K. Net income was -$14.2M. Statements: https://lician.com/financials/brtx
BioRestorative Therapies Inc (BRTX) market capitalization is $10.2M on the latest cached snapshot.
BioRestorative Therapies Inc (BRTX) cached previous close $1.75; day range $1.44 – $1.71; volume 32,119. Session quote: https://lician.com/quote/brtx
BioRestorative Therapies Inc (BRTX) latest cached earnings event is "BRTX earnings" on Sep 8, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BRTX filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/brtx